• 제목/요약/키워드: NF-${\kappa}B$ inhibitory activity

검색결과 169건 처리시간 0.034초

하고초물추출물이 LPS로 활성화된 Raw 264.7 cell에서의 염증매개물질 억제효과 (Inhibitory Effects of Water Extracy of Prunellae Spica on the Production of Pro-inflammatory Mediator in LPS-activated Raw 264.7 Cells)

  • 장현주;박숙자;이종록;김상찬
    • 동의생리병리학회지
    • /
    • 제23권3호
    • /
    • pp.599-607
    • /
    • 2009
  • Prunellae Spica is the spike or whole plant of Prunella vulgaris Linne, which has been used for clearing heat from the liver, brightening the eyes and treating headache in traditional oriental medicines. This study was conducted to evaluate the inhibitory effects of the aqueous extract of Prunellae Spica (PSE; PS extract) on the production of NO and PGE2 in LPS-activated Raw 264.7 cells. Cell viability was determined by MTT assay, and all three doses of PS extract (0.03, 0.1 and 0.3 mg/ml) had no significant cytotoxicity during the entire experimental period. The cells were treated with 1 ${\mu}g/ml$ of LPS 1 h before adding PS extract, and increased NO and PGE2 production were detected in LPS-activated cells compared to control. However, these increases were dose-dependently attenuated by treatment with PS extract. The inhibition of NO by PS extract was due to the suppression of iNOS expression via inhibition of $NF{\kappa}B$ nuclear translocation and proteolytic degradation of $I{\kappa}B{\alpha}$. The decreased level of PGE2 was derived from inhibition of COX-2 activity, but expression of COX-2 protein was not affected by PS extract. Moreover, PS extract reduced the elevated production of IL-${\beta}$ and IL-6 by LPS. These results demonstrate that PS extract has inhibitory effects on the production of NO and PGE2 as a consequence of the reduction of proinflammatory cytokines, especially IL-${\beta}$ and IL-6 in LPS-activated Raw 264.7 cells.

유방암세포에서 구절초 추출물의 암전이 억제 효과 (Chrysanthemum zawadskii var. latilobum Extracts Inhibits of TPA-induced Invasion by Reducing MMP-9 Expression Via the Suppression of NF-${\kappa}B$ Activation in MCF-7 Human Breast Carcinoma Cells)

  • 황진기;김정미;김미성;김하림;박연주;유용욱;권강범;이영래
    • 동의생리병리학회지
    • /
    • 제27권6호
    • /
    • pp.782-788
    • /
    • 2013
  • Chrysanthemum zawadskii Herbich var. latilobum Kitamura (Compositae), colloquially known "Gujulcho" in Korea, has been used in traditional medicine for the treatment of various diseases, including cough, common cold, bladder-related disorders, gastroenteric disorders, hypertension, and inflammatory diseases, such as pneumonia, bronchitis, pharyngitis, and rheumatoid arthritis (RA) However, the effect of Chrysanthemum zawadskii var. latilobum on breast cancer invasion is unknown. In this study, we investigated the inhibitory effect of Chrysanthemum zawadskii var. latilobum extract (CZE) on 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced matrix metalloproteinase-9 (MMP-9) expression and cell invasion, as well as the molecular mechanisms involved in MCF-7 cells. CZE were not cytotoxic up to 100 ${\mu}g/ml$ concentration in the MCF-7 cell line. CZE decreased MMP-9 expression. TPA substantially increased NF-${\kappa}B$ DNA binding activity. Pre-treatment with CZE inhibited TPA-stimulated NF-${\kappa}B$ binding activity and NF-${\kappa}B$ related protein expression. To identify invasion ability of MCF-7 cells decreased by CZE, we used martrigel invasion assay. As a result, it is significantly decreased cell invasion. These results indicate that CZE-mediated inhibition of TPA-induced MMP-9 expression and cell invasion involves the suppression of the NF-${\kappa}B$ pathway in MCF-7 cells. Chrysanthemum zawadskii var. latilobum may have potential value in restricting breast cancer metastasis.

대식세포에서 산화질소 생성에 대한 당귀(當歸) 에탄올 추출물의 억제효과 (Inhibitory Effect of Angelica gigas Nakai Extract on Nitric Oxide Production in RAW 264.7 Cells)

  • 정미영;박히준;정지행;김진용;강전모;이나경;임사비나
    • 대한한의학회지
    • /
    • 제28권2호통권70호
    • /
    • pp.155-165
    • /
    • 2007
  • Objective : The Angelica gigas Nakai ethanol extract (AGE) was investigated to compare nitric oxide (NO) production and $NF-{\kappa}B$ activity from RAW 264.7 cells, since NO and nuclear $factor-{\kappa}B$ $(NF-{\kappa}B)$ have been shown to be factors implicated in inflammatory disease. Method : AGE was prepared by extracting medicinal herb with 70% (v/v) ethanol solution. We investigated production of nitric oxide (NO) and inducible nitric oxide synthase (iNOS) gene expression by ARE in LPS-stimulated RAW 264.7 macrophage cells. We also investigated inhibition of LPS-induced activation of $NF-{\kappa}B$ on western blot. Result : LPS-induced RAW 264.7 cells increased NO production and iNOS expression. Upon treatment with AGE, nitrite production was significantly inhibited in a concentration-dependent manner compared to the untreated control. AGE inhibited this LPS-induced iNOS mRNA and protein in a dose-dependent manner. AGE markedly inhibited the expression of iNOS mRNA and protein at a concentration of 100 ${\mu}g/ml$. LPS-induced RAW 264.7 cells with AGE blocked inhibitory $factor-{\kappa}B{\alpha}$ degradation. Conclusion :This study shows that AGE seems to attenuate inflammation through inhibition of NO production and iNOS expression by blockade of $NF-{\kappa}B$ activation in LPS-stimulated RAW 264.7 cells.

  • PDF

오배산가미(五倍散加味)가 점막(粘膜) 및 피부질환(皮膚疾患)에 미치는 영향 (The effects of Ohbaesangami (OBSGM) on the mucosa and skin diseases)

  • 노석선;홍석훈
    • 한방안이비인후피부과학회지
    • /
    • 제20권2호통권33호
    • /
    • pp.10-35
    • /
    • 2007
  • Objectives : To investigate the effects of Ohbaesangami (OBSGM) on mucosa and skin diseases, anti-microbial and anti-inflammatory tests were performed using several in vitro test models. Results : In anti-microbial test, OBSGM showed the slight inhibitory effect against Propionibacterium acnes (P. acnes) and Staphylococcus aureus (S. aureus). In anti-oxidant test, OBSGM showed the potent radical scavenging activity. In anti-inflammatory test, OBSGM weakly inhibited the lipopolysaccharide (LPS)-induced nitric oxide(NO) release from the RAW 264.7 macrophage cells. OBSGM also inhibited the LPS-induced $interleukin-1{\beta}(IL-1{\beta})$ and cyclooxygenase-2 (COX-2) expressions. The inhibitory effects of OBSGM on macrophage activation was via the inhibition of $NF-{\kappa}B$, evidenced by transient transfection assay. Furthermore, OBSGM markedly inhibited the activation of Jun-N-terminal kinase (JNK) and p38 MAP kinase in RAW 264.7 cells. In skin wrinkle formation assay, OBSGM strongly inhibited collagnease and elastase, whose activities are tightly related with the wrinkle formation. In addition, OBSGM inhibited the activities of MMP-1, MMP-2 on the mRNA levels in RAW 264.7 cells. However, OBSGM did not show an inhibitory potential on tyrosinase activity and melanin synthesis, indicating that it could not be applicable for skin whitening. Conclusion : These results suggest that the anti-inflammatory effect of OBSGM may be due to its inhibitory potentials on the macrophage activation. And, the anti-wrinkle effects of OBSGM may be due to its inhibitory potential on the collagnease and elastase activities. Therefore, OBSGM could be applicable for the treatment of mucosa and skin diseases.

  • PDF

간경화 동물모델에서 Chimeric decoy oligodeoxynucleotide로 억제되는 NF-κB와 Sp1 전사인자 발현 억제 효과에 대한 연구 (Inhibitory Effects of Chimeric Decoy Oligodeoxynucleotide in the Regulation of Transcription Factors NF-κB and Sp1 in an Animal Model of Liver Cirrhosis)

  • 김경현;박지현;김수정;이우람;장영채;김현철;박관규
    • 생명과학회지
    • /
    • 제19권10호
    • /
    • pp.1360-1367
    • /
    • 2009
  • 간섬유화는 지속적인 간세포 손상에 대한 수복현상으로 일어나며, 급성 염증반응과 같은 손상이 주어진 후에는 간세포의 괴사 및 세포외기질의 축적이 일어나게 된다. 간섬유화에 대한 새로운 치료방법을 모색하기 위하여 본 연구에서는 간섬유화 과정에서 염증 반응과 관련된 NF-$\kappa$B와 세포외기질의 축적과 관련된 Sp1전사인자를 동시에 조절하여 간섬유화 억제효과를 관찰하고자 하였다. 전사인자인 Sp1과 NF-$\kappa$B를 동시에 억제하기 위하여 한 분자 내에 Sp1과 NF-$\kappa$B의 전사인자와 결합하는 부위를 가지는 Chimeric (Chi) decoy oligodeoxynucleotide (ODN)을 제작하였다. Chi decoy ODN은 활성화된 간성상세포에서 간섬유화 와 관련된 유전자 발현을 억제시켰으며, 섬유화 동물모델에서도 간 조직의 염증 반응 및 섬유화 관련 인자의 발현을 현저히 억제시켰다. 따라서 Chi decoy ODN은 간섬유화 및 활성화된 간성상세포의 활성을 억제할 수 있는 유전자 치료제로 고려될 수 있을 것으로 사료된다.

내독소에 의한 말초혈액 단핵구의 IL-8 및 IL-$1{\beta}$ 유전자 발현에서 산소기 역할에 관한 연구 (Role of Oxygen Free Radical in the Expression of Interleukin-8 and Interleukin-$1{\beta}$ Gene in Mononuclear Phagocytic Cells)

  • 강민종;김재열;박재석;이승준;유철규;김영환;한성구;심영수
    • Tuberculosis and Respiratory Diseases
    • /
    • 제42권6호
    • /
    • pp.862-870
    • /
    • 1995
  • 연구배경: 산소기의 작용은 과거에는 세포독성이 주로 알려져 있었던 반면, 최근 들어 산소기의 세포내 신호전달체계에서의 역할에 많은 사람의 관심이 모이고 있다. 여러 cytokine의 전사인자(transcription factor)로 작용하는 $NF{\kappa}B$는 기저상태에서는 세포질에 존재하는데 $I{\kappa}B$와 결합되어 핵내로의 이동이 억제되고 있다. 여러 연구에 의해 $NF{\kappa}B$$I{\kappa}B$로부터의 분리는 외부자극에 의해 생성된 산소기에 의한 것으로 알려졌는데, 이렇게 하여 분리된 $NF{\kappa}B$가 핵내로 이동하면 핵내에서 전사인자로 작용하여 여러 유전자의 전사를 증가시키는 것이 보고되었다. IL-8 유전자는 5'flanking promotor region에 $NF{\kappa}B$-like motif가 있어 핵내 $NF{\kappa}B$ activity의 증가로 IL-8 유전자의 전사가 증가되는 것으로 알려졌고, 또한 내독소는 핵내의 $NF{\kappa}B$ activity의 증가와 함께 호중구에서의 산소기의 분비를 가져온다. 이러한 사실로부터 내독소에 의한 IL-8 유전자의 발현은 세포내에서 생성된 산소기에 의해 $NF{\kappa}B$$I{\kappa}B$로부터 분리되어 핵내로 이동하고 이로 인해 IL-8 유전자의 전사가 증가되는 가설을 생각할 수 있다. 저자들은 이러한 가설 검정의 첫번째 단계로써 체내 염증반응에서 중요한 역할을 하는 말초혈액 단핵구의 IL-8 및 IL-$1{\beta}$ 유전자 발현에 세포내의 산소기가 관여하는지의 여부를 평가하고자 본 연구를 시행하였다. 방법: Ficoll-Hypaque density gradient 법과 plastic 부착법을 이용하여 말초혈액 단핵구를 분리하였다. 외부에서 투여한 산소기의 농도에 따른 IL-8 및 IL-$1{\beta}$ mRNA 발현의 유무를 관찰하기 위하여 $H_2O_2$를 0, 10, 100, $300{\mu}M/L$, 1mM/L의 농도로 투여하고 6시간이 경과한후 IL-8 및 IL-$1{\beta}$에 대한 Northern blot analysis를 시행하였다. 시간에 따른 IL-8 및 IL-$1{\beta}$ mRNA 변화를 관찰하고자 $H_2O_2$$100{\mu}M/L$의 농도로 투여하고 0, 2, 4, 6, 8, 24시간이 경과한 후 Northern blot analysis를 시행하였다. 항산화제가 내독소에 의한 IL-8과 IL-$1{\beta}$ mRNA 발현에 미치는 영향을 평가하기 위하여 TMTU(10 mM/L) 1시간; PDTC($100{\mu}M/L$) 1시간, NAC(10 mM/L) 2.5시간, ME(10mM/(L) 2.5시간, Desferrioxamine(100mM/L) 15시간 동안 전처치 한 디음 내독소를 투여허여 4시간이 경과한 후 IL-8 및 IL-$1{\beta}$ mRNA에 대한 Northern blot analysis를 시행하였다. 결과: $H_2O_2$농도 및 시간에 따른 말초혈액 단핵구에서의 IL-8 및 IL-$1{\beta}$ mRNA의 발현에는 유의한 차이가 관찰되지 않았지만 항산화제로 전처치하였을 때 내독소에 의한 말초혈액 단핵구에서의 IL-8 및 IL-$1{\beta}$ mRNA의 발현이 억제되었고 그 억제정도는 TMTU에서 가장 현저하였다. 결론: 이상의 결과에서 말초혈액 단핵구에서의 IL-8 및 IL-$1{\beta}$ mRNA 발현에 $H_2O_2$가 아닌 다른 산소기가 일부 관여할 것으로 생각된다.

  • PDF

혈관평활근세포에서 HSP90에 의한 CXCL10 증가에 관여하는 인자에 대한 연구 (Vascular Smooth Muscle Cells Secrete CXCL10 in Response to Heat Shock Protein 90)

  • 임병용;김도형;김관회
    • 생명과학회지
    • /
    • 제21권5호
    • /
    • pp.664-670
    • /
    • 2011
  • Heat shock protein (HSP)은 외부적인 자극에 반응하여 세포를 보호하는 역할을 한다. 또한 HSP90은 혈관질환에서 처럼 세포가 사멸되거나 손상을 입는 경우 세포 밖으로 유리된다. 그러나 지금까지 세포 밖 HSP90이 혈관평활근세포에 어떠한 영향을 주는지에 대한 연구는 미약하다. 따라서 본 연구는 혈관평활근세포에서 HSP90이 CXCL10 발현에 대한 영향과 그 기전을 규명하였다. HSP90에 노출된 혈관평활근세포에서 CXCL10 transcript가 증가하고, CXCL10 단백질의 분비가 증가되었다. HSP90에 의한 CXCL10 분비는 Toll-like receptor (TLR)-2/-4 억제제인 1-palmitoyl-2-arachidonosyl-sn-phosphatidylcholine (OxPAPC)과 NADPH oxidase 억제제인 diphenyleneiodium 그리고 Akt 경로를 억제하는 LY294002와 Akti IV에 의하여 크게 감소되었다. 또한 TLR-4의 dimerization을 저해하는 curcumin 역시 HSP90에 의한 CXCL10의 분비를 억제하였다. 전사인자인 nuclear factor kappa B(NF-${\kappa}$B)의 생물학적 억제제인 inhibitory kappa B (I${\kappa}$B)와 NF-${\kappa}$B 억제작용이 있는 rasveratrol은 HSP90에 의한 CXCL10 분비를 억제하였다. 이러한 결과는 혈관평활근세포에서 HSP90에 의한 CXCL10의 발현에 TLR-4와 Akt 및 NF-${\kappa}$B가 관여함을 의미한다.

DA-9601, Artemisia Asiatica Herbal Extract, Ameliorates Airway Inflammation of Allergic Asthma in Mice

  • Kim, Ji Young;Kim, Dae Yong;Lee, Yun Song;Lee, Bong Ki;Lee, Kyung-Hoon;Ro, Jai Youl
    • Molecules and Cells
    • /
    • 제22권1호
    • /
    • pp.104-112
    • /
    • 2006
  • We previously reported that DA-9601, ethanol herbal extract of Artemisia asiatica, inhibited histamine and leukotriene releases in guinea pig lung mast cells activated with specific antigen/antibody reaction. This study aimed to evaluate the inhibitory effect of DA-9601 on the OVA-induced airway inflammation in allergic asthma mouse model. BALB/c mice were sensitized and challenged with OVA. DA-9601 was administered orally 1 h before every local OVA-challenge. OVA-specific serum IgE was measured by ELISA, recruitment of inflammatory cells in BAL fluids and lung tissues by Diff-Quik and H&E staining, respectively, the expressions of CD40, CD40L and VCAM-1 by immunohistochemistry, goblet cell hyperplasia by PAS staining, activities of MMPs by gelatin zymography, expressions of mRNA and proteins of cytokines by RT-PCR and ELISA, activities of MAP kinases by western blot, and activity of NF-${\kappa}B$ by EMSA. DA-9601 reduced IgE level, recruitment of inflammatory cells into the BAL fluid and lung tissues, expressions of CD40, CD40L and VCAM-1 molecules, goblet cell hyperplasia, MMPs activity, expressions of mRNA and productions of various cytokines, activities of MAP kinases and NK-${\kappa}B$ increased from OVA-challenged mice. These data suggest that DA-9601 may be developed as a clinical therapeutic agent in allergic diseases due to suppressing the airway allergic inflammation via regulation of various cellular molecules expressed by MAP kinases/NF-${\kappa}B$ pathway.

Estragole Exhibits Anti-inflammatory Activity with the Regulation of NF-κB and Nrf-2 Signaling Pathways in LPS-induced RAW 264.7 cells

  • Roy, Anupom;Park, Hee-Juhn;Jung, Hyun Ah;Choi, Jae Sue
    • Natural Product Sciences
    • /
    • 제24권1호
    • /
    • pp.13-20
    • /
    • 2018
  • Estragole is a naturally occurring phenylpropanoid obtained from essential oils found in a broad diversity of plants. Although the phenylpropanoids show many biological activities, clear regulation of the inflammatory signaling pathways has not yet been determined. Here, we scrutinized the anti-inflammatory effect of estragole. The anti-inflammatory effect of estragole was determined through the inhibitory mechanisms of inducible nitric oxide synthase (iNOS), cyclooxygenase (COX-2), nuclear factor kappa B ($NF-{\kappa}B$), and mitogen-activated protein kinases (MAPK) pathways and the activation of nuclear factor erythroid 2-related factor 2 (Nrf-2)/heme oxygenase (HO)-1 pathways in lipopolysaccharide (LPS)-stimulated RAW 264.7 cells. Estragole significantly inhibited NO production, iNOS and COX-2 expression as well as LPS-induced $NF-{\kappa}B$ and MAPK activation. Furthermore, estragole suppressed LPS-induced intracellular ROS production but up-regulated the stress response gene HO-1 via the activation of transcription factor Nrf-2. These findings demonstrate that estragole inhibits the LPS-induced expression of inflammatory mediators via the down-regulation of iNOS, COX-2, $NF-{\kappa}B$, and MAPK pathways, as well as the up-regulation of the Nrf-2/HO-1 pathway, indicating that this phenylpropanoid has potential therapeutic and preventive applications in various inflammatory diseases.

A Medium-Chain Fatty Acid, Capric Acid, Inhibits RANKL-Induced Osteoclast Differentiation via the Suppression of NF-κB Signaling and Blocks Cytoskeletal Organization and Survival in Mature Osteoclasts

  • Kim, Hyun-Ju;Yoon, Hye-Jin;Kim, Shin-Yoon;Yoon, Young-Ran
    • Molecules and Cells
    • /
    • 제37권8호
    • /
    • pp.598-604
    • /
    • 2014
  • Fatty acids, important components of a normal diet, have been reported to play a role in bone metabolism. Osteoclasts are bone-resorbing cells that are responsible for many bone-destructive diseases such as osteoporosis. In this study, we investigated the impact of a medium-chain fatty acid, capric acid, on the osteoclast differentiation, function, and survival induced by receptor activator of NF-${\kappa}B$ ligand (RANKL) and macrophage colony-stimulating factor (M-CSF). Capric acid inhibited RANKL-mediated osteoclastogenesis in bone marrow-derived macrophages and suppressed RANKL-induced $I{\kappa}B{\alpha}$ phosphorylation, p65 nuclear translocation, and NF-${\kappa}B$ transcriptional activity. Capric acid further blocked the RANKL-stimulated activation of ERK without affecting JNK or p38. The induction of NFATc1 in response to RANKL was also attenuated by capric acid. In addition, capric acid abrogated M-CSF and RANKL-mediated cytoskeleton reorganization, which is crucial for the efficient bone resorption of osteoclasts. Capric acid also increased apoptosis in mature osteoclasts through the induction of Bim expression and the suppression of ERK activation by M-CSF. Together, our results reveal that capric acid has inhibitory effects on osteoclast development. We therefore suggest that capric acid may have potential therapeutic implications for the treatment of bone resorption-associated disorders.